Literature DB >> 21385912

Vascular invasion in hepatocellular carcinoma: is there a correlation with MRI?

N Griffin1, H Addley, E Sala, A S Shaw, L A Grant, H Eldaly, S E Davies, T Prevost, G J Alexander, D J Lomas.   

Abstract

OBJECTIVE: Hepatocellular carcinoma (HCC) is one of the commonest malignancies worldwide. Prognosis is predicted by size at diagnosis, vascular invasion and tumour proliferation markers. This study investigates if MRI features of histologically proven HCCs correlate with vascular invasion.
METHODS: Between 2006 and 2008, 18 consecutive patients, with a total of 27 HCCs, had comprehensive MRI studies performed at our institution within a median of 36 days of histology sampling. Each lesion was evaluated independently on MRI by 3 radiologists (blinded to both the radiology and histopathology reports) using a 5-point confidence scale for 23 specific imaging features. The mean of the rating scores across readers was calculated to determine interobserver consistency. The most consistent features were then used to examine the value of features in predicting vascular invasion, using a χ(2 )test for trend, having eliminated those features without sufficient variability.
RESULTS: 22 of the 23 imaging features showed sufficient variability across lesions. None of these significantly correlated with the presence of vascular invasion, although a trend was identified with the presence of washout in the portal venous phase on MRI and the median size of lesions, which was greater with vascular invasion.
CONCLUSION: This study suggests that no single MRI feature accurately predicts the presence of vascular invasion in HCCs, although a trend was seen with the presence of washout in the portal venous phase post gadolinium. Larger prospective studies are required to investigate this further.

Entities:  

Mesh:

Year:  2011        PMID: 21385912      PMCID: PMC3474106          DOI: 10.1259/bjr/94924398

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  37 in total

1.  Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver.

Authors:  A Rode; B Bancel; P Douek; M Chevallier; V Vilgrain; G Picaud; L Henry; F Berger; T Bizollon; J L Gaudin; C Ducerf
Journal:  J Comput Assist Tomogr       Date:  2001 May-Jun       Impact factor: 1.826

2.  MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation.

Authors:  Marta Burrel; Josep M Llovet; Carmen Ayuso; Carmela Iglesias; Margarita Sala; Rosa Miquel; Teresa Caralt; Juan Ramon Ayuso; Manel Solé; Marcelo Sanchez; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2003-10       Impact factor: 17.425

3.  T2-weighted MR imaging in the assessment of cirrhotic liver.

Authors:  Hero K Hussain; Ibrahim Syed; Hanh V Nghiem; Timothy D Johnson; Ruth C Carlos; William J Weadock; Isaac R Francis
Journal:  Radiology       Date:  2004-01-22       Impact factor: 11.105

4.  Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation.

Authors:  G A Krinsky; V S Lee; N D Theise; J C Weinreb; N M Rofsky; T Diflo; L W Teperman
Journal:  Radiology       Date:  2001-05       Impact factor: 11.105

5.  Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials.

Authors:  T Ono; A Yamanoi; O Nazmy El Assal; H Kohno; N Nagasue
Journal:  Cancer       Date:  2001-06-15       Impact factor: 6.860

6.  Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver.

Authors:  Mohamed Abdel-Wahab; Tarek Salah El-Husseiny; Ehab El Hanafy; Mohamed El Shobary; Emad Hamdy
Journal:  Langenbecks Arch Surg       Date:  2010-04-02       Impact factor: 3.445

7.  Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.

Authors:  Wen-He Zhao; Zhi-Min Ma; Xing-Ren Zhou; Yi-Zheng Feng; Bao-Shan Fang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

8.  Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system.

Authors:  S Iwatsuki; I Dvorchik; J W Marsh; J R Madariaga; B Carr; J J Fung; T E Starzl
Journal:  J Am Coll Surg       Date:  2000-10       Impact factor: 6.113

Review 9.  Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation.

Authors:  Shahid M Hussain; Pieter E Zondervan; Jan N M IJzermans; Solko W Schalm; Rob A de Man; Gabriel P Krestin
Journal:  Radiographics       Date:  2002 Sep-Oct       Impact factor: 5.333

10.  Predictors and patterns of recurrence after resection of hepatocellular carcinoma.

Authors:  Charles Cha; Yuman Fong; William R Jarnagin; Leslie H Blumgart; Ronald P DeMatteo
Journal:  J Am Coll Surg       Date:  2003-11       Impact factor: 6.113

View more
  5 in total

Review 1.  Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging.

Authors:  E Sala; E Mema; Y Himoto; H Veeraraghavan; J D Brenton; A Snyder; B Weigelt; H A Vargas
Journal:  Clin Radiol       Date:  2016-10-11       Impact factor: 2.350

2.  Application of ultrasound combined with enhanced MRI by Gd-BOPTA in diagnosing hepatocellular carcinoma.

Authors:  Shuwen Ji; Ziyong Wang; Shiyong Xia
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 3.  Imaging genomics in cancer research: limitations and promises.

Authors:  Harrison X Bai; Ashley M Lee; Li Yang; Paul Zhang; Christos Davatzikos; John M Maris; Sharon J Diskin
Journal:  Br J Radiol       Date:  2016-02-11       Impact factor: 3.039

Review 4.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-10       Impact factor: 11.105

Review 5.  Combining molecular and imaging metrics in cancer: radiogenomics.

Authors:  Roberto Lo Gullo; Isaac Daimiel; Elizabeth A Morris; Katja Pinker
Journal:  Insights Imaging       Date:  2020-01-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.